On or around 06/03/2019 (Ongoing date of last review)
Filing Date: June 03, 2019
According to the Complaint, Aratana is a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats.
This action stems from a proposed transaction announced on April 26, 2019, pursuant to which Aratana Therapeutics, Inc. will be acquired by Elanco Animal Health Incorporated. On April 26, 2019, Aratana’s Board of Directors caused the Company to enter into an agreement and plan of merger with Elanco. Pursuant to the terms of the Merger Agreement, Aratana’s stockholders will receive 0.1481 shares of Elanco stock and one contingent value right for each share of Aratana common stock they own.
On May 30, 2019, Defendants filed a Registration Statement with the United States Securities and Exchange Commission in connection with the Proposed Transaction. The Complaint alleges that the Registration Statement omits material information with respect to the Proposed Transaction, which renders the Registration Statement false and misleading.
Company & Securities Information
Defendant: Aratana Therapeutics, Inc.
Industry: Biotechnology & Drugs
Headquarters: United States
Ticker Symbol: PETX
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Jordan Rosenblatt, et al. v. Aratana Therapeutics, Inc., et al.